Kornelia Polyak, M.D., Ph.D., Harvard Stem Cell Institute (IMAGE)
Caption
Harvard Stem Cell Institute principal faculty member Kornelia Polyak, of Dana-Farber Cancer Institute and Harvard Medical School, lead the study that identified p27 as a possible marker for breast cancer risk.
Credit
B. D. Colen/Harvard University
Usage Restrictions
This image may ONLY be used with stories about the work described in the accompanying press release.
License
Licensed content